nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimantadine—Amantadine—ABCB1—colon cancer	0.0425	1	CrCbGaD
Rimantadine—Cerebrovascular disorder—Fluorouracil—colon cancer	0.0373	0.039	CcSEcCtD
Rimantadine—Gastrointestinal symptom NOS—Fluorouracil—colon cancer	0.0284	0.0297	CcSEcCtD
Rimantadine—Lacrimation increased—Irinotecan—colon cancer	0.0189	0.0198	CcSEcCtD
Rimantadine—Gait disturbance—Vincristine—colon cancer	0.0183	0.0192	CcSEcCtD
Rimantadine—Lacrimation increased—Fluorouracil—colon cancer	0.0181	0.0189	CcSEcCtD
Rimantadine—Gait disturbance—Irinotecan—colon cancer	0.0179	0.0187	CcSEcCtD
Rimantadine—Ageusia—Capecitabine—colon cancer	0.0144	0.015	CcSEcCtD
Rimantadine—Euphoric mood—Fluorouracil—colon cancer	0.0143	0.015	CcSEcCtD
Rimantadine—Rigors—Capecitabine—colon cancer	0.0143	0.0149	CcSEcCtD
Rimantadine—Lacrimation increased—Capecitabine—colon cancer	0.0127	0.0132	CcSEcCtD
Rimantadine—Cardiac failure—Fluorouracil—colon cancer	0.0124	0.013	CcSEcCtD
Rimantadine—Ataxia—Vincristine—colon cancer	0.0122	0.0128	CcSEcCtD
Rimantadine—Gait disturbance—Capecitabine—colon cancer	0.012	0.0125	CcSEcCtD
Rimantadine—Ataxia—Fluorouracil—colon cancer	0.0114	0.0119	CcSEcCtD
Rimantadine—Sweating increased—Irinotecan—colon cancer	0.0107	0.0111	CcSEcCtD
Rimantadine—Dysphagia—Fluorouracil—colon cancer	0.0105	0.0109	CcSEcCtD
Rimantadine—Mental disability—Capecitabine—colon cancer	0.0101	0.0106	CcSEcCtD
Rimantadine—Depression—Vincristine—colon cancer	0.00999	0.0104	CcSEcCtD
Rimantadine—Stomatitis—Vincristine—colon cancer	0.00976	0.0102	CcSEcCtD
Rimantadine—Stomatitis—Irinotecan—colon cancer	0.00951	0.00993	CcSEcCtD
Rimantadine—Eye pain—Capecitabine—colon cancer	0.00938	0.0098	CcSEcCtD
Rimantadine—Stomatitis—Fluorouracil—colon cancer	0.00911	0.00951	CcSEcCtD
Rimantadine—Hallucination—Vincristine—colon cancer	0.00895	0.00934	CcSEcCtD
Rimantadine—Hypoaesthesia—Vincristine—colon cancer	0.00895	0.00934	CcSEcCtD
Rimantadine—Cardiac failure—Capecitabine—colon cancer	0.00868	0.00906	CcSEcCtD
Rimantadine—Hypoaesthesia—Fluorouracil—colon cancer	0.00834	0.00871	CcSEcCtD
Rimantadine—Ataxia—Capecitabine—colon cancer	0.00796	0.00832	CcSEcCtD
Rimantadine—Chills—Irinotecan—colon cancer	0.00786	0.0082	CcSEcCtD
Rimantadine—Dysphagia—Capecitabine—colon cancer	0.00732	0.00765	CcSEcCtD
Rimantadine—Bronchospasm—Capecitabine—colon cancer	0.0072	0.00752	CcSEcCtD
Rimantadine—Agitation—Vincristine—colon cancer	0.00719	0.00751	CcSEcCtD
Rimantadine—Sweating increased—Capecitabine—colon cancer	0.00713	0.00745	CcSEcCtD
Rimantadine—Syncope—Irinotecan—colon cancer	0.00684	0.00714	CcSEcCtD
Rimantadine—Convulsion—Vincristine—colon cancer	0.00678	0.00708	CcSEcCtD
Rimantadine—Hypertension—Vincristine—colon cancer	0.00676	0.00706	CcSEcCtD
Rimantadine—Loss of consciousness—Irinotecan—colon cancer	0.0067	0.007	CcSEcCtD
Rimantadine—Cough—Irinotecan—colon cancer	0.00665	0.00695	CcSEcCtD
Rimantadine—Hypertension—Irinotecan—colon cancer	0.00658	0.00687	CcSEcCtD
Rimantadine—Depression—Capecitabine—colon cancer	0.00651	0.0068	CcSEcCtD
Rimantadine—Stomatitis—Capecitabine—colon cancer	0.00636	0.00665	CcSEcCtD
Rimantadine—Convulsion—Fluorouracil—colon cancer	0.00632	0.00661	CcSEcCtD
Rimantadine—Confusional state—Irinotecan—colon cancer	0.00627	0.00655	CcSEcCtD
Rimantadine—Hyperhidrosis—Vincristine—colon cancer	0.00617	0.00645	CcSEcCtD
Rimantadine—Shock—Irinotecan—colon cancer	0.00612	0.00639	CcSEcCtD
Rimantadine—Anorexia—Vincristine—colon cancer	0.00609	0.00636	CcSEcCtD
Rimantadine—Hyperhidrosis—Irinotecan—colon cancer	0.00601	0.00628	CcSEcCtD
Rimantadine—Confusional state—Fluorouracil—colon cancer	0.00601	0.00627	CcSEcCtD
Rimantadine—Anorexia—Irinotecan—colon cancer	0.00593	0.00619	CcSEcCtD
Rimantadine—Ataxia—Methotrexate—colon cancer	0.00593	0.00619	CcSEcCtD
Rimantadine—Hypoaesthesia—Capecitabine—colon cancer	0.00583	0.00609	CcSEcCtD
Rimantadine—Tachycardia—Fluorouracil—colon cancer	0.00581	0.00607	CcSEcCtD
Rimantadine—Insomnia—Vincristine—colon cancer	0.00578	0.00603	CcSEcCtD
Rimantadine—Oedema peripheral—Capecitabine—colon cancer	0.00577	0.00603	CcSEcCtD
Rimantadine—Anorexia—Fluorouracil—colon cancer	0.00568	0.00593	CcSEcCtD
Rimantadine—Insomnia—Irinotecan—colon cancer	0.00563	0.00588	CcSEcCtD
Rimantadine—Decreased appetite—Vincristine—colon cancer	0.00555	0.0058	CcSEcCtD
Rimantadine—Dyspnoea—Irinotecan—colon cancer	0.00555	0.00579	CcSEcCtD
Rimantadine—Somnolence—Irinotecan—colon cancer	0.00553	0.00578	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Vincristine—colon cancer	0.00551	0.00576	CcSEcCtD
Rimantadine—Fatigue—Vincristine—colon cancer	0.00551	0.00575	CcSEcCtD
Rimantadine—Dyspepsia—Irinotecan—colon cancer	0.00548	0.00572	CcSEcCtD
Rimantadine—Tinnitus—Capecitabine—colon cancer	0.00546	0.00571	CcSEcCtD
Rimantadine—Constipation—Vincristine—colon cancer	0.00546	0.0057	CcSEcCtD
Rimantadine—Decreased appetite—Irinotecan—colon cancer	0.00541	0.00565	CcSEcCtD
Rimantadine—Insomnia—Fluorouracil—colon cancer	0.00539	0.00563	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00537	0.00561	CcSEcCtD
Rimantadine—Fatigue—Irinotecan—colon cancer	0.00536	0.0056	CcSEcCtD
Rimantadine—Constipation—Irinotecan—colon cancer	0.00532	0.00556	CcSEcCtD
Rimantadine—Dyspnoea—Fluorouracil—colon cancer	0.00531	0.00555	CcSEcCtD
Rimantadine—Somnolence—Fluorouracil—colon cancer	0.0053	0.00553	CcSEcCtD
Rimantadine—Chills—Capecitabine—colon cancer	0.00526	0.00549	CcSEcCtD
Rimantadine—Dyspepsia—Fluorouracil—colon cancer	0.00524	0.00548	CcSEcCtD
Rimantadine—Gastrointestinal pain—Vincristine—colon cancer	0.00522	0.00545	CcSEcCtD
Rimantadine—Decreased appetite—Fluorouracil—colon cancer	0.00518	0.00541	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00514	0.00537	CcSEcCtD
Rimantadine—Feeling abnormal—Irinotecan—colon cancer	0.00513	0.00535	CcSEcCtD
Rimantadine—Gastrointestinal pain—Irinotecan—colon cancer	0.00509	0.00531	CcSEcCtD
Rimantadine—Abdominal pain—Vincristine—colon cancer	0.00505	0.00527	CcSEcCtD
Rimantadine—Abdominal pain—Irinotecan—colon cancer	0.00492	0.00514	CcSEcCtD
Rimantadine—Feeling abnormal—Fluorouracil—colon cancer	0.00491	0.00513	CcSEcCtD
Rimantadine—Depression—Methotrexate—colon cancer	0.00485	0.00506	CcSEcCtD
Rimantadine—Tremor—Capecitabine—colon cancer	0.00478	0.00499	CcSEcCtD
Rimantadine—Stomatitis—Methotrexate—colon cancer	0.00474	0.00495	CcSEcCtD
Rimantadine—Asthenia—Vincristine—colon cancer	0.00458	0.00479	CcSEcCtD
Rimantadine—Syncope—Capecitabine—colon cancer	0.00457	0.00478	CcSEcCtD
Rimantadine—Palpitations—Capecitabine—colon cancer	0.00451	0.00471	CcSEcCtD
Rimantadine—Loss of consciousness—Capecitabine—colon cancer	0.00448	0.00468	CcSEcCtD
Rimantadine—Asthenia—Irinotecan—colon cancer	0.00446	0.00466	CcSEcCtD
Rimantadine—Cough—Capecitabine—colon cancer	0.00445	0.00465	CcSEcCtD
Rimantadine—Hypertension—Capecitabine—colon cancer	0.0044	0.0046	CcSEcCtD
Rimantadine—Diarrhoea—Vincristine—colon cancer	0.00437	0.00456	CcSEcCtD
Rimantadine—Anxiety—Capecitabine—colon cancer	0.00433	0.00452	CcSEcCtD
Rimantadine—Diarrhoea—Irinotecan—colon cancer	0.00426	0.00444	CcSEcCtD
Rimantadine—Dry mouth—Capecitabine—colon cancer	0.00425	0.00444	CcSEcCtD
Rimantadine—Dizziness—Vincristine—colon cancer	0.00422	0.00441	CcSEcCtD
Rimantadine—Confusional state—Capecitabine—colon cancer	0.0042	0.00438	CcSEcCtD
Rimantadine—Dizziness—Irinotecan—colon cancer	0.00411	0.0043	CcSEcCtD
Rimantadine—Shock—Capecitabine—colon cancer	0.0041	0.00428	CcSEcCtD
Rimantadine—Diarrhoea—Fluorouracil—colon cancer	0.00408	0.00426	CcSEcCtD
Rimantadine—Tinnitus—Methotrexate—colon cancer	0.00407	0.00425	CcSEcCtD
Rimantadine—Tachycardia—Capecitabine—colon cancer	0.00406	0.00424	CcSEcCtD
Rimantadine—Vomiting—Vincristine—colon cancer	0.00406	0.00424	CcSEcCtD
Rimantadine—Rash—Vincristine—colon cancer	0.00403	0.00421	CcSEcCtD
Rimantadine—Hyperhidrosis—Capecitabine—colon cancer	0.00402	0.0042	CcSEcCtD
Rimantadine—Dermatitis—Vincristine—colon cancer	0.00402	0.0042	CcSEcCtD
Rimantadine—Headache—Vincristine—colon cancer	0.004	0.00418	CcSEcCtD
Rimantadine—Anorexia—Capecitabine—colon cancer	0.00397	0.00414	CcSEcCtD
Rimantadine—Vomiting—Irinotecan—colon cancer	0.00396	0.00413	CcSEcCtD
Rimantadine—Dizziness—Fluorouracil—colon cancer	0.00394	0.00411	CcSEcCtD
Rimantadine—Rash—Irinotecan—colon cancer	0.00392	0.0041	CcSEcCtD
Rimantadine—Dermatitis—Irinotecan—colon cancer	0.00392	0.00409	CcSEcCtD
Rimantadine—Chills—Methotrexate—colon cancer	0.00391	0.00409	CcSEcCtD
Rimantadine—Headache—Irinotecan—colon cancer	0.0039	0.00407	CcSEcCtD
Rimantadine—Nausea—Vincristine—colon cancer	0.00379	0.00396	CcSEcCtD
Rimantadine—Vomiting—Fluorouracil—colon cancer	0.00379	0.00396	CcSEcCtD
Rimantadine—Insomnia—Capecitabine—colon cancer	0.00377	0.00393	CcSEcCtD
Rimantadine—Rash—Fluorouracil—colon cancer	0.00376	0.00392	CcSEcCtD
Rimantadine—Dermatitis—Fluorouracil—colon cancer	0.00375	0.00392	CcSEcCtD
Rimantadine—Headache—Fluorouracil—colon cancer	0.00373	0.0039	CcSEcCtD
Rimantadine—Dyspnoea—Capecitabine—colon cancer	0.00371	0.00388	CcSEcCtD
Rimantadine—Nausea—Irinotecan—colon cancer	0.00369	0.00386	CcSEcCtD
Rimantadine—Dyspepsia—Capecitabine—colon cancer	0.00366	0.00383	CcSEcCtD
Rimantadine—Decreased appetite—Capecitabine—colon cancer	0.00362	0.00378	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Capecitabine—colon cancer	0.00359	0.00375	CcSEcCtD
Rimantadine—Fatigue—Capecitabine—colon cancer	0.00359	0.00375	CcSEcCtD
Rimantadine—Constipation—Capecitabine—colon cancer	0.00356	0.00372	CcSEcCtD
Rimantadine—Nausea—Fluorouracil—colon cancer	0.00354	0.0037	CcSEcCtD
Rimantadine—Feeling abnormal—Capecitabine—colon cancer	0.00343	0.00358	CcSEcCtD
Rimantadine—Gastrointestinal pain—Capecitabine—colon cancer	0.0034	0.00356	CcSEcCtD
Rimantadine—Cough—Methotrexate—colon cancer	0.00331	0.00346	CcSEcCtD
Rimantadine—Abdominal pain—Capecitabine—colon cancer	0.00329	0.00344	CcSEcCtD
Rimantadine—Convulsion—Methotrexate—colon cancer	0.00329	0.00344	CcSEcCtD
Rimantadine—Confusional state—Methotrexate—colon cancer	0.00313	0.00326	CcSEcCtD
Rimantadine—Hyperhidrosis—Methotrexate—colon cancer	0.003	0.00313	CcSEcCtD
Rimantadine—Asthenia—Capecitabine—colon cancer	0.00299	0.00312	CcSEcCtD
Rimantadine—Anorexia—Methotrexate—colon cancer	0.00295	0.00309	CcSEcCtD
Rimantadine—Diarrhoea—Capecitabine—colon cancer	0.00285	0.00297	CcSEcCtD
Rimantadine—Insomnia—Methotrexate—colon cancer	0.0028	0.00293	CcSEcCtD
Rimantadine—Dyspnoea—Methotrexate—colon cancer	0.00276	0.00289	CcSEcCtD
Rimantadine—Somnolence—Methotrexate—colon cancer	0.00276	0.00288	CcSEcCtD
Rimantadine—Dizziness—Capecitabine—colon cancer	0.00275	0.00288	CcSEcCtD
Rimantadine—Dyspepsia—Methotrexate—colon cancer	0.00273	0.00285	CcSEcCtD
Rimantadine—Decreased appetite—Methotrexate—colon cancer	0.00269	0.00281	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Methotrexate—colon cancer	0.00268	0.00279	CcSEcCtD
Rimantadine—Fatigue—Methotrexate—colon cancer	0.00267	0.00279	CcSEcCtD
Rimantadine—Vomiting—Capecitabine—colon cancer	0.00265	0.00276	CcSEcCtD
Rimantadine—Rash—Capecitabine—colon cancer	0.00263	0.00274	CcSEcCtD
Rimantadine—Dermatitis—Capecitabine—colon cancer	0.00262	0.00274	CcSEcCtD
Rimantadine—Headache—Capecitabine—colon cancer	0.00261	0.00272	CcSEcCtD
Rimantadine—Feeling abnormal—Methotrexate—colon cancer	0.00255	0.00267	CcSEcCtD
Rimantadine—Gastrointestinal pain—Methotrexate—colon cancer	0.00253	0.00265	CcSEcCtD
Rimantadine—Nausea—Capecitabine—colon cancer	0.00247	0.00258	CcSEcCtD
Rimantadine—Abdominal pain—Methotrexate—colon cancer	0.00245	0.00256	CcSEcCtD
Rimantadine—Asthenia—Methotrexate—colon cancer	0.00222	0.00232	CcSEcCtD
Rimantadine—Diarrhoea—Methotrexate—colon cancer	0.00212	0.00221	CcSEcCtD
Rimantadine—Dizziness—Methotrexate—colon cancer	0.00205	0.00214	CcSEcCtD
Rimantadine—Vomiting—Methotrexate—colon cancer	0.00197	0.00206	CcSEcCtD
Rimantadine—Rash—Methotrexate—colon cancer	0.00195	0.00204	CcSEcCtD
Rimantadine—Dermatitis—Methotrexate—colon cancer	0.00195	0.00204	CcSEcCtD
Rimantadine—Headache—Methotrexate—colon cancer	0.00194	0.00203	CcSEcCtD
Rimantadine—Nausea—Methotrexate—colon cancer	0.00184	0.00192	CcSEcCtD
